2017
DOI: 10.1016/j.tmrv.2016.11.001
|View full text |Cite
|
Sign up to set email alerts
|

The History and Challenges of Blood Donor Screening in China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
40
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(40 citation statements)
references
References 2 publications
0
40
0
Order By: Relevance
“…Additionally, in China, screening of blood donors and surgical patients for HIV, hepatitis B virus, hepatitis C virus, and syphilis have been successively required since the 1990s, which facilitated the active identification of new and past infections of these pathogens. 8,9 However, further studies are needed to assess actual incidence trends.…”
Section: Threats Of Vector-borne Zoonotic Disease In Europe: Dogs Drmentioning
confidence: 99%
“…Additionally, in China, screening of blood donors and surgical patients for HIV, hepatitis B virus, hepatitis C virus, and syphilis have been successively required since the 1990s, which facilitated the active identification of new and past infections of these pathogens. 8,9 However, further studies are needed to assess actual incidence trends.…”
Section: Threats Of Vector-borne Zoonotic Disease In Europe: Dogs Drmentioning
confidence: 99%
“…Findings of this study highlight the important role of predonation HBsAg RT in China. In addition to its rapid availability of test result, predonation HBsAg RT is a cost‐effective strategy to conserve blood center resources while significantly reducing HBV risk . In other resource‐limited HBV‐endemic regions such as West Africa, HBsAg RT may be a viable economical option.…”
Section: Discussionmentioning
confidence: 99%
“…The high HBV prevalence among eligible blood donors continuously poses threats to Chinese blood safety. The standard donor selection and donation screening (SC) process implemented in late 1990s has significantly reduced the transfusion‐transmitted HBV infection rate . Yet the HBV residual risks are still high in many regions, with nucleic acid testing (NAT) yield reportedly varying from one in 17,501 in Shenzhen, one in 1853 in Anhui, and one in 1056 in Zhejiang…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Since establishing the blood services, China had experienced several catastrophes with transfusion-transmitted diseases in the past, but since 1998 has undergone transformative changes in donor screening and donor testing. Donor selection is now voluntary donation with fixed groups and donated blood undergoes two rounds of testing with different equipment or reagents by different personnel [11]. Since 2010, nucleic acid test [NAT] was established in several blood centers and in 2015 the government invested for nationwide expansion of NAT.…”
Section: Chinamentioning
confidence: 99%